Ignite Creation Date:
2024-05-06 @ 4:14 PM
Last Modification Date:
2024-10-26 @ 2:06 PM
Study NCT ID:
NCT04915755
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2023-08-08
First Post:
2021-06-01
Brief Title:
Efficacy and Safety Comparison of Niraparib to Placebo in Participants With Human Epidermal Growth Factor 2 Negative HER2- Breast Cancer Susceptibility Gene Mutation BRCAmut or Triple-Negative Breast Cancer TNBC With Molecular Disease
Sponsor:
Organization:
GlaxoSmithKline